Spero Therapeutics Stock Forward View - Double Exponential Smoothing
| SPRO Stock | USD 2.47 -0.11 -4.26% |
The reference data on this page reflects Double Exponential Smoothing output applied to Spero Therapeutics's historical daily closing prices. Forecast values and accuracy statistics are presented for informational purposes.
The Double Exponential Smoothing forecasted value of Spero Therapeutics on the next trading day is expected to be 2.48 with a mean absolute deviation of 0.05 and the sum of the absolute errors of 2.95.When Spero Therapeutics prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any Spero Therapeutics trend in the prices. So in double exponential smoothing past observations are given exponentially smaller weights as the observations get older. In other words, recent Spero Therapeutics observations are given relatively more weight in forecasting than the older observations. The forecast reference data presented here for Spero Therapeutics reflects Double Exponential Smoothing model output and is intended as reference material for analytical use. Double Exponential Smoothing Price Forecast For the 20th of March
Given 90 days horizon, the Double Exponential Smoothing forecasted value of Spero Therapeutics on the next trading day is expected to be 2.48 with a mean absolute deviation of 0.05 , mean absolute percentage error of 0.0043 , and the sum of the absolute errors of 2.95 .Please note that although there have been many attempts to predict Spero Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Spero Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Spero Therapeutics | Spero Therapeutics Price Prediction | Research Analysis |
Forecasted Value
This next-day forecast for Spero Therapeutics uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. At the moment, the model places downside around 0.02 and upside around 5.08 for the forecasting period.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Spero Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Spero Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | 0.0078 |
| MAD | Mean absolute deviation | 0.0501 |
| MAPE | Mean absolute percentage error | 0.0211 |
| SAE | Sum of the absolute errors | 2.9531 |
Other Forecasting Options for Spero Therapeutics
Understanding Spero Therapeutics' price movement is a prerequisite for any investor considering Spero as a position. Spero Stock price charts are frequently cluttered with noise that can interfere with accurate interpretation.Spero Therapeutics Related Equities
The following equities are related to Spero Therapeutics within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Spero Therapeutics against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Spero Therapeutics Market Strength Events
For traders and investors in Spero Therapeutics, market strength indicators offer a quantitative framework for evaluating the stock's responsiveness to market conditions. These tools help identify when trading Spero Therapeutics shares is most likely to generate favorable returns.
Spero Therapeutics Risk Indicators
Analyzing Spero Therapeutics' risk indicators provides a critical input for price forecasting and investment risk management. By quantifying the risk in Spero Therapeutics' investment, investors can make more informed decisions about their exposure and hedging strategies.
| Mean Deviation | 1.82 | |||
| Semi Deviation | 2.02 | |||
| Standard Deviation | 2.48 | |||
| Variance | 6.13 | |||
| Downside Variance | 4.99 | |||
| Semi Variance | 4.08 | |||
| Expected Short fall | -2.18 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Spero Therapeutics
The amount of media and story coverage tied to Spero Therapeutics can signal where market attention is concentrating at the moment. A disciplined read of coverage helps investors separate durable relevance from temporary noise.
Contributor Headline
Latest Perspective From Macroaxis
Spero Therapeutics Short Properties
Short sentiment tied to Spero Therapeutics matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 54 M | |
| Cash And Short Term Investments | 52.9 M |